Selexipag - Actelion/Nippon Shinyaku
At a glance
- Drug Originator Nippon Shinyaku
- Drug Licenced by Actelion Pharmaceuticals
- Drug Class Acetamides; Amines; Anti-inflammatories; Antithrombotics; Pyrazines; Small molecules; Sulfonamides; Vascular disorder therapies; Vasodilators
- Mechanism of Action Epoprostenol receptor agonists
- USA Patent Applicants ACTELION
- USA Patents 10
- NDAs 2
- International Patents 153
- Patent Applications 368
Table of Contents

Disclaimer